EFFECT OF INTRAVITREAL TRIAMCINOLONE IN DIABETIC MACULAR EDEMA UNRESPONSIVE TO INTRAVITREAL BEVACIZUMAB
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EFFECT OF INTRAVITREAL TRIAMCINOLONE IN DIABETIC MACULAR EDEMA UNRESPONSIVE TO INTRAVITREAL BEVACIZUMAB
Authors
Keywords
-
Journal
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Volume 34, Issue 8, Pages 1606-1611
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-02-19
DOI
10.1097/iae.0000000000000109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble Mediators of Diabetic Macular Edema: The Diagnostic Role of Aqueous VEGF and Cytokine Levels in Diabetic Macular Edema
- (2013) Leah A. Owen et al. Current Diabetes Reports
- Intravitreal bevacizumab increases intraocular interleukin-6 levels at 1day after injection in patients with proliferative diabetic retinopathy
- (2012) Sohee Jeon et al. CYTOKINE
- Global Prevalence and Major Risk Factors of Diabetic Retinopathy
- (2012) J. W. Y. Yau et al. DIABETES CARE
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- CYTOKINE CONCENTRATION IN AQUEOUS HUMOR OF EYES WITH DIABETIC MACULAR EDEMA
- (2012) Jost B. Jonas et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection
- (2011) Ji W Lim et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion
- (2011) Yukihiko Suzuki et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Roles of IL-8 in Ocular Inflammations: A Review
- (2011) Hassan Ghasemi et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2011) Michael J. Elman et al. OPHTHALMOLOGY
- Intravitreal Triamcinolone Prior to Laser Treatment of Diabetic Macular Edema
- (2011) Mark C. Gillies et al. OPHTHALMOLOGY
- The RESTORE Study
- (2011) Paul Mitchell et al. OPHTHALMOLOGY
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
- (2010) P. Massin et al. DIABETES CARE
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2010) Quan Dong Nguyen et al. OPHTHALMOLOGY
- ANGIOGENIC AND INFLAMMATORY MARKERS IN THE INTRAOCULAR FLUID OF EYES WITH DIABETIC MACULAR EDEMA AND INFLUENCE OF THERAPY WITH BEVACIZUMAB
- (2010) Marion Funk et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes
- (2009) Ronald Klein et al. OPHTHALMOLOGY
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Purinergic receptor activation inhibits osmotic glial cell swelling in the diabetic rat retina
- (2008) Antje Wurm et al. EXPERIMENTAL EYE RESEARCH
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema
- (2008) OPHTHALMOLOGY
- Effect of Intravitreal Bevacizumab Injection on Aqueous Humor Cytokine Levels in Clinically Significant Macular Edema
- (2008) Mi In Roh et al. OPHTHALMOLOGY
- Association of Vitreous Inflammatory Factors with Diabetic Macular Edema
- (2008) Hideharu Funatsu et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started